EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Classical Effects of FGF23: Molecular and Clinical Features

Luis Martínez-Heredia iD, Juan Manuel Canelo-Moreno iD, Beatriz García-Fontana iD, Manuel Muñoz-Torres iD

International Journal of Molecular Sciences · 30.04.2024 · 25 (9) · 4875

DOI: 10.3390/ijms25094875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2024. Verfasst von Luis Martínez-Heredia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biosanitaria de Granada, 18014 Granada, Spain. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Fibroblast Growth Factors, Phosphates. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Health Carlos III, CIBER of Frailty and Healthy Aging, European Regional Development Fund (FEDER).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article reviews the role of fibroblast growth factor 23 (FGF23) protein in phosphate metabolism, highlighting its regulation of vitamin D, parathyroid hormone, and bone metabolism. Although it was traditionally thought that phosphate–calcium homeostasis was controlled exclusively by parathyroid hormone (PTH) and calcitriol, pathophysiological studies revealed the influence of FGF23. This protein, expressed mainly in bone, inhibits the renal reabsorption of phosphate and calcitriol formation, mediated by the α-klotho co-receptor. In addition to its role in phosphate metabolism, FGF23 exhibits pleiotropic effects in non-renal systems such as the cardiovascular, immune, and metabolic systems, including the regulation of gene expression and cardiac fibrosis. Although it has been proposed as a biomarker and therapeutic target, the inhibition of FGF23 poses challenges due to its potential side effects. However, the approval of drugs such as burosumab represents a milestone in the treatment of FGF23-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23Fibroblast Growth FactorsPhosphatesHumansAnimalsParathyroid HormoneAntibodies, Monoclonal, HumanizedVitamin DBone and BonesKlotho Proteins

Stichwörter der Autor:innen

FGF23KlothoXLHburosumabcalcineurin pathwaychronic kidney disease

Substanzen

Fibroblast Growth Factor-23Fibroblast Growth FactorsFGF23 protein, humanPhosphatesburosumabParathyroid HormoneAntibodies, Monoclonal, HumanizedVitamin DKlotho Proteins

Autor:innen und Institutionen

  • Instituto de Investigación Biosanitaria de Granada, 18014 Granada, Spain.
  • Biomedical Research Network in Fragility and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Endocrinology and Nutrition Unit, University Hospital Juan Ramón Jiménez, 21005 Huelva, Spain.
  • Endocrinology and Nutrition Unit, University Hospital Clínico San Cecilio, 18016 Granada, Spain.
  • Department of Cell Biology, University of Granada, 18016 Granada, Spain.
  • Department of Medicine, University of Granada, 18016 Granada, Spain.

ORCID-Profile: Luis Martínez-Heredia, Juan Manuel Canelo-Moreno, Beatriz García-Fontana, Manuel Muñoz-Torres

Förderung

  • Institute of Health Carlos III
  • CIBER of Frailty and Healthy Aging
  • European Regional Development Fund (FEDER)

Zitieren

APA

Martínez-Heredia, L., Canelo-Moreno, J. M., García-Fontana, B., & Muñoz-Torres, M. (2024). Non-Classical Effects of FGF23: Molecular and Clinical Features. International Journal of Molecular Sciences, 25(9), 4875. https://doi.org/10.3390/ijms25094875

Vancouver

Martínez-Heredia L, Canelo-Moreno JM, García-Fontana B, Muñoz-Torres M. Non-Classical Effects of FGF23: Molecular and Clinical Features. International Journal of Molecular Sciences. 2024;25(9):4875. doi:10.3390/ijms25094875

BibTeX
@article{MartnezHeredia2024,
  author = {Martínez-Heredia, Luis and Canelo-Moreno, Juan Manuel and García-Fontana, Beatriz and Muñoz-Torres, Manuel},
  title = {Non-Classical Effects of FGF23: Molecular and Clinical Features},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {9},
  pages = {4875},
  doi = {10.3390/ijms25094875}
}
Kostenlos starten →